Swain, S.M.; Macharia, H.; Cortes, J.; Dang, C.; Gianni, L.; Hurvitz, S.A.; Jackisch, C.; Schneeweiss, A.; Slamon, D.; Valagussa, P.;
et al. Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis. Cancers 2022, 14, 5051.
https://doi.org/10.3390/cancers14205051
AMA Style
Swain SM, Macharia H, Cortes J, Dang C, Gianni L, Hurvitz SA, Jackisch C, Schneeweiss A, Slamon D, Valagussa P,
et al. Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis. Cancers. 2022; 14(20):5051.
https://doi.org/10.3390/cancers14205051
Chicago/Turabian Style
Swain, Sandra M., Harrison Macharia, Javier Cortes, Chau Dang, Luca Gianni, Sara A. Hurvitz, Christian Jackisch, Andreas Schneeweiss, Dennis Slamon, Pinuccia Valagussa,
and et al. 2022. "Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis" Cancers 14, no. 20: 5051.
https://doi.org/10.3390/cancers14205051
APA Style
Swain, S. M., Macharia, H., Cortes, J., Dang, C., Gianni, L., Hurvitz, S. A., Jackisch, C., Schneeweiss, A., Slamon, D., Valagussa, P., du Toit, Y., Heinzmann, D., Knott, A., Song, C., & Cortazar, P.
(2022). Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis. Cancers, 14(20), 5051.
https://doi.org/10.3390/cancers14205051
